BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2468794)

  • 1. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients.
    Stamey TA; Kabalin JN
    J Urol; 1989 May; 141(5):1070-5. PubMed ID: 2468794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients.
    Stamey TA; Kabalin JN; McNeal JE; Johnstone IM; Freiha F; Redwine EA; Yang N
    J Urol; 1989 May; 141(5):1076-83. PubMed ID: 2468795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients.
    Stamey TA; Kabalin JN; Ferrari M
    J Urol; 1989 May; 141(5):1084-7. PubMed ID: 2468796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. IV. Anti-androgen treated patients.
    Stamey TA; Kabalin JN; Ferrari M; Yang N
    J Urol; 1989 May; 141(5):1088-90. PubMed ID: 2468797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of serum prostate specific antigen determinations before and after radical prostatectomy.
    Lange PH; Ercole CJ; Lightner DJ; Fraley EE; Vessella R
    J Urol; 1989 Apr; 141(4):873-9. PubMed ID: 2467013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.
    Partin AW; Carter HB; Chan DW; Epstein JI; Oesterling JE; Rock RC; Weber JP; Walsh PC
    J Urol; 1990 Apr; 143(4):747-52. PubMed ID: 1690309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of prostate specific antigen as a tumor marker in men with advanced adenocarcinoma of the prostate.
    Maatman TJ
    J Urol; 1989 Jun; 141(6):1378-80. PubMed ID: 2470927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer.
    Carter HB; Partin AW; Epstein JI; Chan DW; Walsh PC
    J Urol; 1990 Nov; 144(5):1167-70; discussion 1170-1. PubMed ID: 1700143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
    Stamey TA; Yang N; Hay AR; McNeal JE; Freiha FS; Redwine E
    N Engl J Med; 1987 Oct; 317(15):909-16. PubMed ID: 2442609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous circadian fluctuations of prostate specific antigen and prostatic acid phosphatase serum activities in patients with prostatic cancer.
    Mannini D; Maver P; Aiello E; Corrado G; Vecchi F; Bellanova B; Marengo M
    Urol Res; 1988; 16(1):9-12. PubMed ID: 2449758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen testing in untreated and treated prostatic adenocarcinoma.
    Rainwater LM; Morgan WR; Klee GG; Zincke H
    Mayo Clin Proc; 1990 Aug; 65(8):1118-26. PubMed ID: 1697014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical use of prostate specific antigen in patients with prostate cancer.
    Hudson MA; Bahnson RR; Catalona WJ
    J Urol; 1989 Oct; 142(4):1011-7. PubMed ID: 2477559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of prostate-specific antigen in the diagnosis and treatment of prostatic adenocarcinoma].
    Stamey TA
    Urologe A; 1990 Mar; 29(2):52-64. PubMed ID: 1691883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of fluctuation of serum tumor markers in advanced cancer of prostate.
    Maatman TJ
    Urology; 1993 Dec; 42(6):672-6. PubMed ID: 7504849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.
    Ercole CJ; Lange PH; Mathisen M; Chiou RK; Reddy PK; Vessella RL
    J Urol; 1987 Nov; 138(5):1181-4. PubMed ID: 2444720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters.
    Chybowski FM; Keller JJ; Bergstralh EJ; Oesterling JE
    J Urol; 1991 Feb; 145(2):313-8. PubMed ID: 1703240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen and external beam radiation therapy in prostate cancer.
    Zagars GK; Sherman NE; Babaian RJ
    Cancer; 1991 Jan; 67(2):412-20. PubMed ID: 1702349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.
    Oesterling JE; Chan DW; Epstein JI; Kimball AW; Bruzek DJ; Rock RC; Brendler CB; Walsh PC
    J Urol; 1988 Apr; 139(4):766-72. PubMed ID: 2451037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation).
    Morgan WR; Zincke H; Rainwater LM; Myers RP; Klee GG
    J Urol; 1991 Feb; 145(2):319-23. PubMed ID: 1703241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma].
    Haukaas S; Skaarland E; Halvorsen OJ; Stensland E; Farstad M
    Tidsskr Nor Laegeforen; 1990 Sep; 110(23):2990-3. PubMed ID: 1700496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.